Federal authorities charged John Thomas Howard, treasurer and director of Canadian healthcare company CANARX, with smuggling, conspiracy, and importing misbranded drugs. He was arrested Nov. 8 in the Detroit-Canada tunnel. His brother Bob Howard, president of CANARX, faces similar charges and was being sought as of last week.
The case marks the first criminal prosecution by U.S. authorities against a company operating as an alternative funding program, or AFP. These programs promise to lower prescription drug costs by sourcing cheaper medications from international markets. The FDA and Department of Homeland Security say the business model is illegal and poses health risks because drugs intended for foreign markets are unregulated and may be counterfeit.
CANARX, based in Windsor, Ontario, was established in 2002. Joseph Morris, the company's general counsel, said last week that the Howard brothers "deny all the charges against them, will defend vigorously, and expect to be vindicated in court."
The FDA's investigation began with a tip about ScriptSourcing, a Florida-based AFP founded by Gary Becker. By May 2026, Becker became a cooperating witness for the government against CANARX after the FDA learned that medications from ScriptSourcing's program had harmed at least two patients. One patient was hospitalized with a bowel obstruction after using misbranded Mounjaro from a Canadian pharmacy; another was seriously injured after receiving counterfeit medication.
Becker provided the FDA a spreadsheet showing ScriptSourcing dispensed approximately 16,549 prescription drugs sourced from CANARX between 2021 and 2026. Recorded phone calls from June and July 2026 showed John Howard "was aware of the routes for importation of drugs from Canada into the United States" and that both brothers knew the drugs were illegal to import, according to FDA special agent Dustin Dobbs' affidavit.
ScriptSourcing is no longer in business.